Davis B J, Almekinder J L, Flagler N, Travlos G, Wilson R, Maronpot R R
Department of Microbiology, Parasitology, and Pathology, College of Veterinary Medicine, North Carolina State University, Raleigh 27606, USA.
Toxicol Appl Pharmacol. 1997 Feb;142(2):328-37. doi: 10.1006/taap.1996.8035.
These studies define the site and mechanisms of reproductive toxicity of ethylene glycol monomethyl ether (EGME) in a nongravid female animal model using in vivo and in vitro methods. In vivo studies assessed vaginal cytology and histology, ovarian histology, and serum hormones in 80- to 90-day-old, adult, regularly cycling, female Sprague-Dawley rats treated daily with EGME or vehicle by oral gavage. Dose-response and time-course studies (four to nine rats per group per treatment) determined that 300 mg/kg EGME suppressed cyclicity without systemic toxicity within 3 to 8 days, and doses less than 100 mg/kg had no effect. Pathogenesis studies (six to nine rats per time and treatment) determined that 300 mg/kg EGME elevated serum progesterone within 32 hr after dosing, while serum estradiol, FSH, LH, and prolactin remained at baseline levels. In EGME-treated rats, cyclicity was suppressed, ovulation was inhibited, and corpora lutea were hypertrophied. Thus, EGME appeared to target the ovarian luteal cell. To further examine the toxicity in vitro, luteal cells were recovered from 23-day-old, hCG-primed Sprague-Dawley rats and treated with 0-10 mM methoxy acetic acid (MAA), the proximate toxic metabolite of EGME. MAA (1-10 mM) maintained elevated progesterone levels as production declined in untreated cells at 24 and 48 hr of culture. Progesterone production was maintained independent of LH-stimulated cAMP levels. MAA decreased ATP, but only at 48 hr and at 2.5 mM or greater concentrations. Thus, these studies establish that the ovarian luteal cell is a target of EGME and MAA in vivo and in vitro and that the effect on luteal cell progesterone production is likely independent of LH-stimulated cAMP pathways.
这些研究使用体内和体外方法,在非妊娠雌性动物模型中确定了乙二醇单甲醚(EGME)的生殖毒性部位和机制。体内研究评估了80至90日龄、成年、月经周期正常的雌性Sprague-Dawley大鼠的阴道细胞学和组织学、卵巢组织学以及血清激素,这些大鼠每天通过口服灌胃给予EGME或赋形剂。剂量反应和时间进程研究(每组每次处理4至9只大鼠)确定,300mg/kg的EGME在3至8天内抑制了月经周期,且无全身毒性,而低于100mg/kg的剂量则无影响。发病机制研究(每次处理6至9只大鼠)确定,300mg/kg的EGME在给药后32小时内使血清孕酮升高,而血清雌二醇、促卵泡激素、促黄体生成素和催乳素保持在基线水平。在接受EGME治疗的大鼠中,月经周期受到抑制,排卵受到抑制,黄体肥大。因此,EGME似乎靶向卵巢黄体细胞。为了进一步研究体外毒性,从23日龄、经人绒毛膜促性腺激素预处理的Sprague-Dawley大鼠中分离黄体细胞,并用0至10mM的甲氧基乙酸(MAA)处理,MAA是EGME的直接毒性代谢产物。在培养24小时和48小时时,未处理细胞的孕酮产量下降,而MAA(1至10mM)可维持孕酮水平升高。孕酮的产生与促黄体生成素刺激的环磷酸腺苷水平无关。MAA降低了三磷酸腺苷(ATP)水平,但仅在48小时以及浓度为2.5mM或更高时出现这种情况。因此,这些研究表明,卵巢黄体细胞是EGME和MAA在体内和体外的作用靶点,并且对黄体细胞孕酮产生的影响可能与促黄体生成素刺激的环磷酸腺苷途径无关。